Mood, Anxiety, and Cognition in Perimenopause
The perimenopausal mood and cognitive picture is real and is one of the most commonly dismissed parts of the transition. Here is what current evidence supports — and how to think about HRT, SSRIs, therapy, and the conditions that need to be screened for separately.
By The HRT Index Editorial Team · Published 2026-05-15 · Last reviewed by editors: 2026-05-26
Editorial research — not medically reviewed by a clinician.
No active affiliate links on this page as of 2026-05-26.
This article is educational and is not medical advice. Consult your clinician before starting, stopping, or changing hormone therapy. Individual responses to HRT vary; the right hormones, doses, and delivery methods for you depend on your medical history and clinical context.
If you are thinking about harming yourself, feel unable to stay safe, or are worried you might act on suicidal thoughts, call or text 988 in the U.S. or seek emergency care now. Mood symptoms during perimenopause are common, but safety comes first.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
- What it asks: your symptoms, age and uterus status, medication route preference, insurance or cash-pay situation, and state
- What you get: a personalized shortlist of online HRT providers matched to your situation, with verified pricing, plus a clear flag when online care isn't the right starting point
- Cost: free · about 60 seconds · no signup
What is happening
The perimenopausal transition is associated with a measurable increase in the risk of new-onset depressive symptoms, particularly in women with a prior history of premenstrual mood symptoms, postpartum depression, or major depressive disorder. Anxiety often presents as a late-luteal-phase pattern that gradually loses its cyclical character as cycles become irregular. The cognitive complaints most commonly described — word-finding difficulty, losing the thread of a sentence, “brain fog” — appear in the perimenopausal years and, for most women, attenuate after the transition is complete.
HRT and mood: what is supported, what is not
Current menopause-society guidance supports a role for estradiol in the treatment of perimenopausal depressive symptoms in some patients, particularly those without a major depressive disorder history whose mood symptoms appeared with the transition itself. HRT is not a first-line treatment for major depressive disorder, and a woman whose depressive symptoms meet the criteria for a major depressive episode should be evaluated for treatment on that basis whether or not she is also a candidate for HRT.
Non-hormonal options
SSRIs and SNRIs have a substantial evidence base for both perimenopausal mood symptoms and vasomotor symptoms; some patients get meaningful improvement in both with one medication. Cognitive behavioral therapy is effective for depression, anxiety, and insomnia and is worth considering alongside or instead of medication. See non-hormonal options for the broader picture.
What needs to be screened for separately
- Thyroid dysfunction — overlaps substantially with perimenopausal mood and cognitive complaints.
- Sleep apnea — under-diagnosed in midlife women and a meaningful driver of low mood and cognitive symptoms.
- Substance use — alcohol intake often rises during the transition and is a meaningful driver of low mood and disrupted sleep.
- Major depressive disorder — needs its own treatment plan, with or without HRT.
Where to start
A clinician comfortable with both hormonal and non-hormonal approaches is the right starting point — most of the comprehensive practices we cover have this scope, and Evernow specifically includes non-hormonal options in its standard formulary. See the provider comparison.
Hormone changes can interact with sleep, hot flashes, anxiety, and mood vulnerability, but HRT is not a substitute for urgent mental health care, bipolar disorder evaluation, substance-use care, trauma care, or treatment of major depression when those are present.
If you are in crisis, call or text 988 (the U.S. Suicide and Crisis Lifeline) or seek emergency care. This page is educational and is not a substitute for clinical evaluation.
Sources used for this guide
This guide was editorially checked against current materials from The Menopause Society, FDA labeling or safety communications for treatments discussed, and relevant peer-reviewed literature on mood, cognition, and anxiety in perimenopause.
Your situation changes the answer
Find My HRT Path
The right online HRT provider isn't the same for every woman. It depends on your symptoms, your age and whether you have a uterus, your medication route preference (patch, pill, gel, or vaginal estrogen), your risk history, your insurance or cash-pay situation, and your state — and some situations belong with an in-person clinician first. Because a general answer can't resolve those for you, use The HRT Index's Find My HRT Path tool to match your situation to the right provider, and to flag when online care isn't the right starting point, before your first consult.
Find My HRT Path →